Cardiovascular Disease

Uncovering the Long-Term CV Risks Following Pregnancy Complications

A Swedish cohort study found that approximately 30% of pregnant women have a major pregnancy complication, which can lead to an elevated risk for ischemic heart disease that persists for decades.

Using data from 2.1M Swedish women, the authors examined five major types of adverse pregnancy outcomes: preterm delivery (< 37 weeks gestation), small for gestational age, preeclampsia, other hypertensive disorders of pregnancy, and gestational diabetes.

Women with one (or more) adverse pregnancy events had increased risk for CAD out to 46 years post-pregnancy.  

  • Over the follow-up period (median 25 years, maximum 46 years), 3.8% of women were diagnosed with ischemic heart disease.
  • 10 years postpartum, those who had pregnancy-related hypertensive disorders had the greatest CAD risk (adjusted HR 2.09), followed by those with preterm delivery (HR 1.72), preeclampsia (HR 1.54), gestational diabetes (HR 1.30), and a small-for-gestational-age infant (HR 1.10).
  • 10-19 years postpartum, having a small-for-gestational-age infant was associated with the highest CAD risk.
  • 20-29 years postpartum, gestational diabetes was associated with the highest risk.
  • 30-46 years postpartum, adjusted hazard ratios for CAD decreased but remained elevated compared with those without adverse pregnancy outcomes. 

The Takeaway

Long-term risks of pregnancy complications often go unmentioned between women and their physicians in routine practice. But this study reveals that adverse pregnancy outcomes are important lifelong risk factors for heart disease, and provide an opportunity to identify high-risk women earlier than with traditional risk factors alone. 

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Electrophysiology August 21, 2025

Conduction-System Pacing Succeeds at Treating AV Block August 21, 2025

Conduction-system pacing could be poised to reshape standard care for atrioventricular (AV) block patients after the randomized CSPACE trial demonstrated its significant benefits over traditional right ventricular septal pacing. Taking a closer look at CSP’s potential, the CSPACE trial enrolled 202 patients with AV block at two Australian hospitals, randomizing them to conduction-system pacing or […]

Cardiology Pharmaceuticals August 18, 2025

Rivaroxaban Monotherapy Could Be Better for CAD + AFib August 18, 2025

New analysis from the AFIRE trial suggests rivaroxaban monotherapy might be emerging as a preferred antithrombotic strategy for patients with AFib and stable coronary artery disease, especially in older age groups. The Post Hoc AFIRE Analysis examined 2,215 Japanese patients with AFib and stable CAD, stratifying them into four age groups (<70, 70-74, 75-79, and […]

Surgeries & Interventions August 14, 2025

TEER Could Save Lives in AFMR Patients August 14, 2025

Shedding light on a new treatment for an understudied condition, data published in EHJ suggests that transcatheter edge-to-edge repair (TEER) delivers significant survival advantages in patients with atrial functional mitral regurgitation (FMR). The new OCEAN-Mitral/REVEAL-AFMR Analysis compared 441 TEER-treated patients against 640 medically managed controls with moderate or severe atrial FMR, stating a solid case […]

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!